Whole Health: All for Lovaza

In the year since it was officially introduced in the United States, Lovaza is on target to top $1 billion in sales this year. The success of this prescription-only omega-3 fish oil capsule from GlaxoSmithKline opens a whole new door for Big Pharma, which has a deepening interest in natural substances to prevent and treat health conditions. The pharmaceutical industry is opening itself up to considering

In the year since it was officially introduced in the United States, Lovaza is on target to top $1 billion in sales this year. The success of this prescription-only omega-3 fish oil capsule from GlaxoSmithKline opens a whole new door for Big Pharma, which has a deepening interest in natural substances to prevent and treat health conditions.

“The pharmaceutical industry is opening itself up to considering natural substances and their clinical benefits,” said Bernardette King, a GSK spo

Register to view the full article

test - Advanced Registered User

Already a member? .